Syncom Formulations (india) Ltd Board of Directors
Board of Directors at Syncom Formulations (India) Ltd
Independent Director
Chairman & Wholetime Director
Independent Director
Independent Director
Whole-time Director
Key Highlights
- Ruchi Jindal joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ritesh Kumar Lunkad joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ankit Jain joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- ANKIT KEDARMAL BANKDA joins the board as Chairman / Executive Director / WTD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vaishali Agrawal continues to serve as the Company Sec. & Compli. Officer in 2025, maintaining the same position as in the previous year.
Syncom Formulations (India) Ltd
NSE: SYNCOMFORMUL
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 23.24 |
| 05 Oct 2026 | 23.12 |
| 01 Oct 2026 | 23.97 |
| 30 Sep 2026 | 25.22 |
| 29 Sep 2026 | 26.32 |
| 28 Sep 2026 | 22.2 |
| 25 Sep 2026 | 20.06 |
| 24 Sep 2026 | 20.09 |
| 23 Sep 2026 | 20.03 |
| 22 Sep 2026 | 20.4 |
Company Fundamentals for Syncom Formulations (India) Ltd
Market Cap
2,184 Cr
EPS
0.9
P/E Ratio (TTM)
25.5
P/B Ratio (TTM)
5.3
Day’s High
23.79
Day’s Low
22.8
DTE
0.0
ROE
18.4
52 Week High
27.53
52 Week Low
10.21
ROCE
24.5
Market Price of Syncom Formulations (India) Ltd
1M
1Y
3Y
5Y
Syncom Formulations (India) Ltd News Hub
Nifty slips below 24,200 level; Nifty bank shares buck trend; HDFC Bank drops 2.93%
The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped bel
Read more
13 Aug 24
Syncom Formulations gains after Q1 PAT rises over 73% YoY
Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure
Read more
13 Aug 24
Syncom Formulations (India) consolidated net profit rises 73.41% in the June 2024 quarter
Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 202
Read more
12 Aug 24
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 Augus
Read more
06 Aug 24
